DFTX · Definium Therapeutics, Inc. · Exempt Offerings
$29.12
-0.26 (-0.88%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$3.99B
Shares
136.90M
Volume · Nov 18
1.92M
Avg daily vol (3M)
1.96M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-05-05 | New | Pharmaceuticals | $7,000,000 | $7,000,000 | 06b |
| 2024-03-18 | New | Pharmaceuticals | $75,000,000 | $75,000,000 | 06b |
| 2021-01-20 | New | Pharmaceuticals | $826,073 | $499,618 | 06b |
| 2020-12-22 | New | Pharmaceuticals | $128,730 | $78,268 | 06b |
| 2020-11-13 | New | Pharmaceuticals | $412,842 | $247,705 | 06b |
| 2020-06-08 | New | Pharmaceuticals | $468,248 | $468,248 | 06b |
Showing 1–6 of 6 filings
Key facts
CIK
1813814
CUSIP
24477V105
13F (30d)
343 filings
335 filers
Visit website
Investor relations